Processa Pharmaceuticals PCSA
NASDAQ PCSA
$2.14 -0.01 (-0.47%)
At close: Aug 20, 2026 · 4:00 PM EDT

Processa Pharmaceuticals (PCSA) Interest Expenses (2012 - 2025)

Processa Pharmaceuticals' (PCSA) quarterly Interest Expenses came in at $18.0 in Q4 2025, down 99.51% on a QoQ basis from $3709.0 in Q3 2025.

Processa Pharmaceuticals (PCSA) Interest Expenses (2012 - 2025) Analysis & Trends

Processa Pharmaceuticals (PCSA) has 14 years of Interest Expenses data on file, last reported at $18.0 in Q4 2025.

  • Quarterly Interest Expenses changed N/A year-over-year to $18.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $201130.0 (changed N/A YoY) and the FY2025 annual result came in at $21.3 million, up 7.15% from the prior year.
  • Interest Expenses eased to $18.0 in Q4 2025, from $3709.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $17.6 million in Q4 2023 to a low of $18.0 in Q4 2025.
  • A 5-year average of $2.0 million and a median of $70040.0 in 2022 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2021 — Interest Expenses slumped 99.8% — and 2023, when it jumped 6304.58%.
  • Tracing PCSA's Interest Expenses over 5 years: stood at $108558.0 in 2021, then surged by 13296.26% to $14.5 million in 2022, then increased by 21.29% to $17.6 million in 2023, then plunged by 99.47% to $93387.0 in 2024, then slumped by 99.98% to $18.0 in 2025.
  • The last three Interest Expenses figures came in at $18.0 (Q4 2025), $3709.0 (Q3 2025), and $3920.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 39.74 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 82.05 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 20.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 93.62 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -4.89 Mn
10 Processa Pharmaceuticals 5.93 Mn 5.93 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 18.00
Dec 31, 2025 18.00
Sep 30, 2025 3,709.00
Sep 30, 2025 3,709.00
Jun 30, 2025 3,920.00
Jun 30, 2025 3,920.00
Sep 30, 2024 93,387.00
Sep 30, 2024 93,387.00
Jun 30, 2024 10,540.00
Jun 30, 2024 10,540.00
Mar 31, 2024 138,287.00
Mar 31, 2024 138,287.00
Dec 31, 2023 17.64 Mn
Dec 31, 2023 17.64 Mn
Sep 30, 2023 186,505.00
Sep 30, 2023 186,505.00
Jun 30, 2023 209,750.00
Jun 30, 2023 209,750.00
Mar 31, 2023 232,996.00
Mar 31, 2023 232,996.00